Evidence map›Paper›PMID 33110145›Full record

ArticleScientific reports2020

NMR microsystem for label-free characterization of 3D nanoliter microtissues.

Marco Grisi, Gaurasundar M Conley, Kyle J Rodriguez, Erika Riva, Lukas Egli, Wolfgang Moritz, Jan Lichtenberg, Jürgen Brugger, Giovanni Boero

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Micro magnetic resonance spectroscopy for noninvasive metabolic screening of mammalian embryos and oocytes.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Marco GrisiAnnaida Technologies SA, Lausanne, Switzerland. marco.grisi@annaida.ch.
Gaurasundar M ConleyAnnaida Technologies SA, Lausanne, Switzerland.
Kyle J RodriguezMicrosystems Laboratory, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Erika RivaService de Gastro-Entérologie et D'hépatologie, CHUV, Epalinges, Switzerland.
Lukas EgliInSphero AG, Schlieren, Switzerland.
Wolfgang MoritzInSphero AG, Schlieren, Switzerland.
Jan LichtenbergInSphero AG, Schlieren, Switzerland.
Jürgen BruggerMicrosystems Laboratory, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Giovanni BoeroMicrosystems Laboratory, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
École Polytechnique Fédérale de Lausanne · CHInspire · CHHôpital Orthopédique de la Suisse Romande · CH

Funding

Swiss National Science Foundation 40B1-0_180268
6 · The paper itself

Abstract

Performing chemical analysis at the nanoliter (nL) scale is of paramount importance for medicine, drug development, toxicology, and research. Despite the numerous methodologies available, a tool for obtaining chemical information non-invasively is still missing at this scale. Observer effects, sample destruction and complex preparatory procedures remain a necessary compromise. Among non-invasive spectroscopic techniques, one able to provide holistic and highly resolved chemical information in-vivo is nuclear magnetic resonance (NMR). For its renowned informative power and ability to foster discoveries and life-saving applications, efficient NMR at microscopic scales is highly sought after, but so far technical limitations could not match the stringent necessities of microbiology, such as biocompatible handling, ease of use, and high throughput. Here we introduce a novel microsystem, which combines CMOS technology with 3D microfabrication, enabling nL NMR as a platform tool for non-invasive spectroscopy of organoids, 3D cell cultures, and early stage embryos. In this study we show its application to microlivers models simulating non-alcoholic fatty liver disease, demonstrating detection of lipid metabolism dynamics in a time frame of 14 days based on 117 measurements of single 3D human liver microtissues.

Identifiers

PMID33110145
PMCPMC7758329
OpenAlexW3097020187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.